ClinVar Miner

Submissions for variant NM_001365999.1(SZT2):c.9460T>C (p.Ser3154Pro)

dbSNP: rs1271549438
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV002313700 SCV000848963 uncertain significance Inborn genetic diseases 2017-02-07 criteria provided, single submitter clinical testing The p.S3097P variant (also known as c.9289T>C), located in coding exon 67 of the SZT2 gene, results from a T to C substitution at nucleotide position 9289. The serine at codon 3097 is replaced by proline, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear.
Invitae RCV001862045 SCV002216568 uncertain significance not provided 2022-01-14 criteria provided, single submitter clinical testing This sequence change replaces serine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 3097 of the SZT2 protein (p.Ser3097Pro). This variant is not present in population databases (gnomAD no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 588763). This variant has not been reported in the literature in individuals affected with SZT2-related conditions.
Genome-Nilou Lab RCV003457767 SCV004178077 uncertain significance Developmental and epileptic encephalopathy, 18 2023-04-11 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.